Floatz logo

Eptacog Alfa

Acquired Haemophilia

Novo Nordisk A/SPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Acquired Haemophilia cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
University Hospital, Rouen
Phase 3B
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
University Hospital, Rouen
Phase 3B
CYCLOSPORIN A
Turkish Society of Hematology
D
Apcc
Turkish Society of Hematology
D
Azathioprine
Turkish Society of Hematology
D
Rhfviia
Turkish Society of Hematology
D
Ddavp
Turkish Society of Hematology
D

Same molecule, other indications

Eptacog Alfa is also rated in:

hemophilia BDormant
A
Indicative ·
84 / 100
View asset →
hemophilia ADormant
A
Indicative ·
84 / 100
View asset →
inherited blood coagulation disorderDormant
A
Indicative ·
82 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →